American International Group’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

American International Group’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,011	Closed	-$43.8K	–	2896
2024 Q1	$43.8K	Sell	12,011 -103	-0.9%	-$395	﹤0.01%	2813
2023 Q4	$36.5K	Sell	12,114 -49	-0.4%	-$99	﹤0.01%	2875
2023 Q3	$26.1K	Buy	12,163 +432	+4%	+$1.73K	﹤0.01%	2954
2023 Q2	$65.7K	Buy	+11,731	New	+$91.8K	﹤0.01%	2805
2022 Q2	–	Sell	-11,058	Closed	-$69K	–	3300
2022 Q1	$69K	Buy	11,058 +7,041	+175%	+$71.9K	﹤0.01%	2734
2021 Q4	$46K	Sell	4,017 -30	-0.7%	-$570	﹤0.01%	2982
2021 Q3	$76K	Buy	+4,047	New	+$77.6K	﹤0.01%	2896

Other funds holding OMGA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

American International Group's OMGA Position: Q2 2024 in Review

American International Group sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q2 2024, closing a stake of 12,011 shares — an estimated $43.8K sold.

American International Group first reported a position in OMGA in Q3 2021 and held it in 7 quarters. The position peaked at $76K in Q3 2021. 68 funds tracked by Wall St. Rank hold OMGA as of Q2 2024.

American International Group reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
American International Group sold 12,011 Omega Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $43.8K.
American International Group first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
American International Group's Omega Therapeutics, Inc. Common Stock position peaked at $76K in Q3 2021.
68 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.